IDA blend vs Kazakhstan: Cause of death, by non-communicable diseases, ages 0-4
IDA blend
7.3%
in 2021
Kazakhstan
40.7%
in 2021
IDA blend rank
40th
Kazakhstan rank
42nd
Cause of death, by non-communicable diseases, ages 0-4 over time
- IDA blend
- Kazakhstan
How they compare
Kazakhstan currently reports 40.7% against 7.3% in IDA blend, a difference of 33.4%.
That makes Kazakhstan's figure about 5.5 times IDA blend's.
Across all 6 years both countries report, Kazakhstan has been ahead every year.
IDA blend ranks 40th and Kazakhstan ranks 42nd of 47 groups.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.2% | 18.9% | 14.8% | Kazakhstan |
| 2010s | 6.3% | 37.6% | 31.3% | Kazakhstan |
| 2020s | 7.3% | 40.9% | 33.6% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, IDA blend or Kazakhstan?
- Kazakhstan, at 40.7% against 7.3% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between IDA blend and Kazakhstan?
- 33.4%, with Kazakhstan ahead.
- How many years of comparable data are there for IDA blend and Kazakhstan?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA blend and Kazakhstan rank globally for cause of death, by non-communicable diseases, ages 0-4?
- IDA blend ranks 40th and Kazakhstan ranks 42nd of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.